Concepedia

Helena Haberstock-Debic

HH

8

Publications

477

Citations

8

H-Index

2003

Active since

Affiliations

Portola Pharmaceuticals (United States)(Current)

Principia Biopharma (United States)

University of California, San Francisco

Helena Haberstock-Debic is an author at Portola Pharmaceuticals (United States) specializing in medicine, health sciences, and opioid overdose.

Top concepts

Publications per year

2003–2022

8

Publications

8

Morphine Promotes Rapid, Arrestin-Dependent Endocytosis of μ-Opioid Receptors in Striatal Neurons

Helena Haberstock-Debic, Kyung‐Ah Kim, Yang Yu et al. · Journal of Neuroscience · 2005 · 144 citations · Full text

Morphine Acutely Regulates Opioid Receptor Trafficking Selectively in Dendrites of Nucleus Accumbens Neurons

Helena Haberstock-Debic, Marc N. Wein, Michel Barrot et al. · Journal of Neuroscience · 2003 · 138 citations · Full text

, , +15

Discovery of Reversible Covalent Bruton’s Tyrosine Kinase Inhibitors PRN473 and PRN1008 (Rilzabrutinib)

Timothy D. Owens, Ken A. Brameld, Erik Verner et al. · Journal of Medicinal Chemistry · 2022 · 65 citations · Full text

A Small Molecule Inhibitor of ITK and RLK Impairs Th1 Differentiation and Prevents Colitis Disease Progression

Hyoung‐Soo Cho, Hyun Mu Shin, Helena Haberstock-Debic et al. · The Journal of Immunology · 2015 · 38 citations · Full text

A Clopidogrel-Insensitive Inducible Pool of P2Y12 Receptors Contributes to Thrombus Formation: Inhibition by Elinogrel, a Direct-Acting, Reversible P2Y12 Antagonist

Helena Haberstock-Debic, Patrick André, Scott Mills et al. · Journal of Pharmacology and Experimental Therapeutics · 2011 · 29 citations

Rows per page

1–5 of 8